Skip to main content
. 2022 Jan 19;8(1):8. doi: 10.3390/ijns8010008
AA Amino acids
ACMG American College of Medical Genetics and Genomics
AO Administrative order (Department of Health—Philippines)
ASA Argininosuccinic aciduria
BIO Biotinidase deficiency
CAH Congenital adrenal hyperplasia
CDC Centers for Disease Control and Prevention (United States)
CF Cystic fibrosis
CH Congenital hypothyroidism
CHGS Center for Human Genetic Services
CNSP California Newborn Screening Program
COVID-19 Coronavirus disease 2019
DOH Department of Health (Philippines)
ENBS Expanded newborn bloodspot screening
FAO Fatty acid oxidation
G6PD Glucose-6-phosphate dehydrogenase
GAL Galactosemia
HCY Homocystinuria
HGB Hemoglobinopathy
IHG Institute of Human Genetics (Philippines)
LIMS Laboratory information management system
LMIC Low- and middle-income countries
MS/MS Tandem mass spectrometry
MSUD Maple syrup urine disease
NBS Newborn bloodspot screening
NBSCC Newborn Screening Continuity Clinic (long-term follow-up)
NCNBSS National comprehensive newborn screening system
NIH National Institutes of Health (Philippines)
NNSGRC National Newborn Screening and Global Resource Center (U.S.)
NSC Newborn Screening Center (screening laboratory)
NSF Newborn Screening Facility (screening specimen collection site)
NSQAP Newborn Screening Quality Assurance Program (U.S.-CDC)
NSRC Newborn Screening Reference Center (Philippines)
NTWG Newborn Screening Technical Working Group
OA Organic acid
PHIC Philippine Health Insurance Corporation (national health insurance)
PKU Phenylketonuria
PNSP Philippine Newborn Screening Program
PT Proficiency testing
QA Quality assurance
QC Quality control
RUSP Recommended uniform screening panel (U.S.)